Edges in Network
Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
Node | ELL2 |
Upstream (Parents) |
---|
(<<) ARHGAP29 → ELL2 |
(<<) TAPT1 → ELL2 |
(<<) PAMR1 → ELL2 |
(<<) MAGEA9B///MAGEA9 → ELL2 |
(<<) RBMS3 → ELL2 |
(<<) TBL1X → ELL2 |
Downstream (Children) |
---|
ELL2 → TAPT1 (>>) |
ELL2 → SORCS3 (>>) |
ELL2 → RAG2 (>>) |
ELL2 → CATR1 (>>) |
ELL2 → DRD1 (>>) |
ELL2 → EDDM3B (>>) |
ELL2 → LOR (>>) |
ELL2 → KRT2 (>>) |
ELL2 → A2BP1 (>>) |
ELL2 → TBL1X (>>) |
ELL2 → FLJ14107 (>>) |